At what cost? Debate rages over cholesterol drugs
August 06, 2015 at 12:13 PM EDT
Estimates of annual spending on PCSK9 drugs have been as high as $150 billion, but drugmakers expect it to be much lower.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.